Alto Ingredients, Inc. (ALTO) Form 8-K — Aug 7, 2026
Alto Ingredients entered into an At-The-Market Issuance Sales Agreement dated August 5, 2026 with Craig-Hallum Capital Group as designated agent, alongside The Benchmark Company and H.C. Wainwright, allowing it to sell up to $50.0 million of common stock from time to time at prevailing market prices. Sales under the program would be made off the company's Form S-3 shelf (No. 333-295723), which was declared effective May 22, 2026, with a prospectus supplement filed August 5, 2026.
Key figures
- Gross Proceeds
- up to $50.0 million (maximum aggregate offering price under the ATM program; no sales yet)
- Agent Commission
- 3.0% of aggregate gross proceeds
- Shelf Registration
- Form S-3 No. 333-295723, filed May 8, 2026, declared effective May 22, 2026
- Common Stock Par Value
- $0.001 per share
- Expense Reimbursement Cap
- $100,000 payable upon execution, plus up to $10,000 per quarter for standard due diligence
Price after filing
Close on the filing date to close N calendar days later (from $4.39). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.